Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog

StatusEnrolling by Invitation
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Enrollment reduced 90% 1000 → 100 participants
See other at-risk trials from Ohio State University

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Enrollment reduced: 1000 → 100 participants Show 5 more changesShow less
    • Enrolling by invitation only
    • Start date: Dec 1, 2026 to Mar 1, 2027
    • Primary endpoints: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 46 words
    • Study description expanded, about 95 words
  2. Notable Start date: Aug 1, 2025 to Dec 1, 2026v4
  3. Notable Start date: Jan 1, 2025 to Aug 1, 2025v3
  4. Notable Primary endpoint revised
    • Study title shortened, about 7 words
    v2
  5. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The purpose of this study is to establish a longitudinal cohort of older adults with Subjective Cognitive Decline (SCD) or Mild Cognitive Impairment (MCI): 1) at heightened risk for dementia, and 2) from underrepresented/under-resourced communities to characterize clinical course. This study will utilize the Tele-Cog clinic as a means for recruiting older adults at risk for dementia from under-resourced and underrepresented communities. Successful completion of this project will increase the opportunity for under-resourced and underrepresented communities to participate in cognitive research.
Trial Details
NCT Number NCT06542458
Lead Sponsor Ohio State University
Conditions
(from sponsor)
Mild Cognitive Impairment, Subjective Cognitive Decline
Related terms Cognitive Dysfunction
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov